Charles Schwab’s Citius Pharmaceuticals CTXR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,043
Closed -$38.1K 3497
2024
Q3
$38.1K Hold
3,043
﹤0.01% 3441
2024
Q2
$44.4K Sell
3,043
-11,237
-79% -$201K ﹤0.01% 3520
2024
Q1
$320K Hold
14,280
﹤0.01% 3163
2023
Q4
$270K Hold
14,280
﹤0.01% 3235
2023
Q3
$244K Hold
14,280
﹤0.01% 3249
2023
Q2
$428K Buy
14,280
+11,237
+369% +$370K ﹤0.01% 3125
2023
Q1
$89K Hold
3,043
﹤0.01% 3266
2022
Q4
$60.1K Hold
3,043
﹤0.01% 3326
2022
Q3
$93K Hold
3,043
﹤0.01% 3229
2022
Q2
$70K Sell
3,043
-11,071
-78% -$304K ﹤0.01% 3334
2022
Q1
$632K Buy
14,114
+2,763
+24% +$109K ﹤0.01% 3032
2021
Q4
$438K Hold
11,351
﹤0.01% 3188
2021
Q3
$577K Hold
11,351
﹤0.01% 3097
2021
Q2
$988K Buy
11,351
+9,630
+560% +$579K ﹤0.01% 2938
2021
Q1
$77K Buy
+1,721
New +$68.5K ﹤0.01% 3401

Other funds holding CTXR